Optimizing Fludrocortisone Therapy and Sodium Management for Orthostatic Symptoms and Hyponatremia

Initial Assessment

Assess mineralocorticoid adequacy because orthostatic symptoms combined with hyponatremia are indicative of under‑replacement of fludrocortisone. 1, 2
Measure seated and standing blood pressure to quantify the orthostatic drop as a primary clinical parameter. 1, 2
Query for salt craving or light‑headedness, which are common clues of insufficient mineralocorticoid effect. 1, 2
Obtain serum sodium and potassium levels to evaluate electrolyte balance. 1, 2
Check plasma renin activity and aim for the upper‑normal range, which serves as a biochemical marker of adequate fludrocortisone dosing. 1, 2

The usual adult dosing range is 0.05 – 0.2 mg daily; doses should be titrated within this window. 1, 2
For patients receiving a low dose (e.g., 0.05 mg), increase to 0.1 mg daily before resorting to aggressive sodium supplementation. 1, 2
Individuals on prednisolone often require a higher fludrocortisone dose than those on hydrocortisone because prednisolone provides less intrinsic mineralocorticoid activity. 1, 2

Advise a liberalized sodium diet (no restriction) as the baseline dietary approach. 1, 2
Implement temporary modest increases in salt intake to relieve acute orthostatic symptoms, avoiding high‑salt regimens that lack supporting evidence. 1, 2

Hyponatremia occurring together with orthostatic symptoms in a fludrocortisone‑treated patient signals inadequate mineralocorticoid replacement. 1, 2
Raising the fludrocortisone dose enhances sodium retention, thereby correcting hyponatremia while simultaneously improving orthostatic tolerance. 1, 2
The underlying pathophysiology is aldosterone deficiency, not SIADH; therefore fluid restriction is inappropriate and may worsen orthostatic hypotension. 1, 2

Re‑measure serum sodium, potassium, and blood pressure 1–2 weeks after any fludrocortisone dose change to ensure therapeutic response and detect excess. 1, 2
If hypertension emerges, first reduce the fludrocortisone dose rather than adding antihypertensive agents. 1

Avoid licorice and grapefruit juice, as they potentiate mineralocorticoid effects and increase the risk of excess. 1, 2
Phenytoin accelerates fludrocortisone metabolism; patients on phenytoin may need a higher fludrocortisone dose to achieve adequate effect. 1, 2

Do not delay fludrocortisone optimization; the coexistence of orthostatic symptoms and hyponatremia should prompt immediate dose reassessment. 1, 2
Do not use diuretics or aldosterone antagonists in adrenal‑insufficient patients, as they can precipitate adrenal crisis. 1

Patients should be explicitly counseled not to restrict dietary salt, because sodium restriction can precipitate an adrenal crisis. 3

In hot climates or situations that cause excessive sweating, a temporary increase of fludrocortisone dose by 50–100 % or a modest rise in dietary salt intake may be recommended to maintain sodium balance. 3

Adequate replacement is suggested by overall well‑being, normal-range electrolytes, and normal blood pressure without postural hypotension. 3